Skip to content

Transcriptomic Profiling in Severely Injured Patients

Transcriptomic Profiling in Severely Injured Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02508272
Enrollment
115
Registered
2015-07-24
Start date
2009-12-31
Completion date
2015-07-31
Last updated
2015-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammation, Sepsis, Trauma

Keywords

Transcriptome profiling

Brief summary

Discovery of differences in the host response in patients with systemic inflammation and sepsis, and identification of novel, specific markers by using a longitudinal clinico-transcriptomic approach.

Detailed description

The aim of this study is to link defined clinical phenotypes with data on RNA obtained from blood samples by high throughput technologies. Genetic and molecular characteristics of the immune system after severe trauma will be crosslinked to clinical aspects of posttraumatic organ failure, with the goal of identifying typical molecular fingerprints. Patients with and without sepsis or organ failure will be compared with the goal to develop a diagnostic test designed to predict the clinical course following severe trauma. Criteria for study enrollment includes patient age ≥18 y, an Injury Severity Score (ISS) ≥ 17 points, and time from injury to admission \< 6 h. Whole blood from trauma patients will be collected within the first 6 h after trauma (day 0) and on days 1, 2, 3, 5, 7, 10, 14, and 21.

Interventions

None listed

Sponsors

University of Zurich
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patient age ≥18 y * Injury Severity Score (ISS) ≥ 17 points * time from injury to admission \< 6 h.

Exclusion criteria

Moribund Patients with: * PH \< 7,1 or * Lactate \> 15 mmol/l or * Base deficit \> 15 mEq/l

Design outcomes

Primary

MeasureTime frame
Systemic Inflammation and Sepsis21 days after trauma

Secondary

MeasureTime frame
Mortality28 days after Trauma
Nosocomial infections21 days after trauma
SOFA score21 days after trauma
Systemic inflammation score21 days after trauma
Hospital length of stay28 days after trauma
ICU length of stay28 days after trauma

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026